95Q-25430-16905
3 vaccinations
8 coded responses
40 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: No appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-13
- 2021-01-20
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesFree text: Injection site redness is hot to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Skin warm — Feeling: Good · Site: Pain, RednessFree text: redness is hot to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-12
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-11-02
Dose 3 — Moderna
- 2021-11-02
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Chills, Tremor — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Significant shaking with chillsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Armpit pain, near injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Epistaxis, Nasal dryness — Feeling: Fair · HeadacheFree text: Dry and bloody nasal passagesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
-
2022-02-01
Survey response — 3 months, dose 3MedDRA: Bronchitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bronchitis (COVID ruled out with negative test)MedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-02
Call successfulDoes not wish to fill out VAERS report
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
Call center
3 call center cases
2 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): No appetite
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Injection site redness is hot to touch
Systemic reaction (other): redness is hot to touch
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Significant shaking with chills
Systemic reaction (other): Armpit pain, near injection site
Systemic reaction (other): Dry and bloody nasal passages
Release 11 — 3 months, dose 3
Symptoms: Bronchitis (COVID ruled out with negative test)
Release 11 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Epistaxis | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Nasal dryness | · | · | ✓ |
| SRO | Skin warm | ✓ | ✓ | ✓ |
| SRO | Tremor | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release